McKesson - 41 Year Stock Price History | MCK
Historical daily share price chart and data for McKesson since 1984 adjusted for splits and dividends. The latest closing stock price for McKesson as of June 13, 2025 is 728.20.
- The all-time high McKesson stock closing price was 730.80 on June 12, 2025.
- The McKesson 52-week high stock price is 732.99, which is 0.7% above the current share price.
- The McKesson 52-week low stock price is 464.42, which is 36.2% below the current share price.
- The average McKesson stock price for the last 52 weeks is 604.37.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| McKesson Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2025 |
656.4452 |
565.0240 |
730.8000 |
565.0240 |
728.2000 |
28.04% |
| 2024 |
543.2385 |
470.2220 |
627.5470 |
470.2220 |
568.7160 |
23.67% |
| 2023 |
401.7902 |
369.6670 |
467.3810 |
331.6770 |
459.8520 |
24.13% |
| 2022 |
323.3001 |
243.5340 |
392.0720 |
240.1080 |
370.4470 |
51.83% |
| 2021 |
194.4581 |
169.6710 |
244.3190 |
164.8940 |
243.9950 |
44.23% |
| 2020 |
147.4592 |
133.5010 |
178.2320 |
111.7290 |
169.1740 |
27.06% |
| 2019 |
127.2184 |
107.5410 |
147.1220 |
106.7170 |
133.1450 |
26.72% |
| 2018 |
131.5345 |
149.6230 |
166.2980 |
102.9380 |
105.0680 |
-28.40% |
| 2017 |
141.0647 |
137.6040 |
157.4770 |
126.2370 |
146.7530 |
11.95% |
| 2016 |
156.0132 |
180.4640 |
184.5710 |
115.6120 |
131.0890 |
-28.30% |
| 2015 |
197.1272 |
191.1320 |
224.1590 |
165.5070 |
182.8370 |
-4.51% |
| 2014 |
172.3026 |
146.9970 |
196.2790 |
146.9970 |
191.4820 |
29.26% |
| 2013 |
112.9394 |
88.9405 |
152.2560 |
88.9405 |
148.1350 |
67.65% |
| 2012 |
80.4451 |
71.8222 |
90.7813 |
68.5264 |
88.3573 |
25.60% |
| 2011 |
70.9847 |
63.6734 |
77.8641 |
62.4609 |
70.3504 |
11.79% |
| 2010 |
57.1872 |
56.0668 |
63.4588 |
51.5716 |
62.9312 |
13.79% |
| 2009 |
42.9899 |
34.1975 |
56.7912 |
29.7657 |
55.3058 |
62.94% |
| 2008 |
45.5240 |
55.5210 |
59.0046 |
24.9741 |
33.9433 |
-40.36% |
| 2007 |
51.3634 |
44.5035 |
58.2054 |
44.2439 |
56.9110 |
29.72% |
| 2006 |
43.7502 |
45.6435 |
47.4560 |
38.8458 |
43.8718 |
-1.25% |
| 2005 |
36.2070 |
26.6079 |
45.3679 |
25.9142 |
44.4292 |
64.91% |
| 2004 |
25.6467 |
26.2202 |
30.5373 |
19.6392 |
26.9419 |
-1.40% |
| 2003 |
25.7356 |
23.5836 |
31.2643 |
19.4209 |
27.3247 |
19.94% |
| 2002 |
27.8921 |
31.3476 |
35.0401 |
21.2334 |
22.7829 |
-27.19% |
| 2001 |
28.7159 |
29.2009 |
34.5691 |
19.9639 |
31.2890 |
4.91% |
| 2000 |
20.2039 |
19.2642 |
29.8242 |
13.2436 |
29.8242 |
61.27% |
| 1999 |
34.2697 |
63.4494 |
72.5792 |
15.9849 |
18.4937 |
-71.34% |
| 1998 |
57.8684 |
43.1419 |
77.1412 |
38.7872 |
64.5205 |
46.97% |
| 1997 |
33.2296 |
22.3640 |
45.7244 |
20.8631 |
43.9015 |
96.30% |
| 1996 |
19.4590 |
19.4071 |
22.6135 |
16.2915 |
22.3640 |
12.68% |
| 1995 |
16.7390 |
12.6392 |
20.4836 |
12.2562 |
19.8482 |
58.84% |
| 1994 |
29.4449 |
19.7338 |
41.2449 |
11.6338 |
12.4956 |
-37.85% |
| 1993 |
17.4087 |
15.3757 |
21.2231 |
14.0245 |
20.1061 |
31.53% |
| 1992 |
12.6652 |
12.6742 |
15.6802 |
10.6996 |
15.2858 |
21.84% |
| 1991 |
11.6550 |
10.8337 |
13.4637 |
10.0130 |
12.5453 |
12.39% |
| 1990 |
10.7134 |
11.4230 |
12.0138 |
8.7873 |
11.1620 |
0.12% |
| 1989 |
10.7716 |
9.9364 |
12.2054 |
9.3887 |
11.1491 |
14.46% |
| 1988 |
10.1755 |
8.5672 |
11.1491 |
8.2934 |
9.7408 |
17.45% |
| 1987 |
10.5043 |
10.2103 |
12.1662 |
7.9804 |
8.2934 |
-16.54% |
| 1986 |
9.3894 |
8.0978 |
10.9535 |
7.7457 |
9.9364 |
21.24% |
| 1985 |
7.0970 |
6.0049 |
8.3521 |
5.8484 |
8.1956 |
36.93% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$91.432B |
$359.051B |
|
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
|
